Celcuity Inc. Form 8-K Summary
Business Context and Reporting Period
Celcuity Inc., an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on August 8, 2019. The filing serves to announce the Company's financial results for the second quarter ended June 30, 2019. The Company's common stock trades on The Nasdaq Stock Market LLC under the symbol "CELC."
Financial Metrics
This Form 8-K does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. The filing explicitly states that the detailed financial results are contained in a press release furnished as Exhibit 99.1, which is incorporated by reference. Consequently, no specific financial metrics can be extracted from the text of this filing alone.
Material Changes
The filing does not provide specific details on material changes versus the prior comparable period. It references the second-quarter results but does not quantify performance shifts within the body of this report.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer that the information in Item 2.02, including the accompanying exhibit, is being "furnished" and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. It further states that this information shall not be incorporated by reference into any other filings. No specific guidance, outlook, or risk factors are detailed in the text of this 8-K.
Key Facts for Investor Verification
- Verify the specific revenue and net loss figures in the press release (Exhibit 99.1) referenced in this filing.
- Confirm the Company's cash position and burn rate as of June 30, 2019, which are not listed in this summary document.
- Review the full text of the press release for any updates on clinical trial progress or regulatory milestones.
- Note that the Company has elected to use the extended transition period for complying with new financial accounting standards as an emerging growth company.